| XLS |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
Equity capital |
Reserves |
Gains/losses recognized |
|
|
| |||||||
|
€ million |
General |
Sub- |
Capital |
Retained |
Remea- |
Available- |
Derivative |
Currency |
Equity |
Non-con- |
Equity | ||
| |||||||||||||
|
Balance as of January 1, 2011 |
397.2 |
168.0 |
3,813.7 |
5,040.9 |
–370.4 |
–3.1 |
–61.1 |
1,344.6 |
10,329.8 |
42.0 |
10,371.8 | ||
|
Adjustment IAS 19 |
– |
– |
– |
–0.6 |
5.4 |
– |
– |
– |
4.8 |
– |
4.8 | ||
|
Balance as of January 1, 2011 adjusted |
397.2 |
168.0 |
3,813.7 |
5,040.3 |
–365.0 |
–3.1 |
–61.1 |
1,344.6 |
10,334.6 |
42.0 |
10,376.6 | ||
|
Profit after tax* |
– |
– |
– |
473.6 |
– |
– |
– |
– |
473.6 |
8.2 |
481.9 | ||
|
Gains/losses recognized immediately in equity* |
– |
– |
– |
– |
0.9 |
0.5 |
–31.8 |
–68.9 |
–99.3 |
–2.7 |
–102.0 | ||
|
Comprehensive income* |
– |
– |
– |
473.6 |
0.9 |
0.5 |
–31.8 |
–68.9 |
374.4 |
5.5 |
379.9 | ||
|
Dividend payments |
– |
– |
– |
–80.8 |
– |
– |
– |
– |
–80.8 |
–3.8 |
–84.6 | ||
|
Profit transfers to/from E. Merck KG including transfers to reserves |
– |
– |
– |
–233.0 |
– |
– |
– |
– |
–233.0 |
– |
–233.0 | ||
|
Changes in scope of consolidation/ |
– |
– |
– |
–1.8 |
– |
– |
– |
– |
–1.8 |
1.4 |
–0.4 | ||
|
Balance as of September 30, 2011* |
397.2 |
168.0 |
3,813.7 |
5,198.3 |
–364.1 |
–2.6 |
–92.9 |
1,275.7 |
10,393.3 |
45.1 |
10,438.4 | ||
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Balance as of January 1, 2012 |
397.2 |
168.0 |
3,813.7 |
5,248.7 |
–390.7 |
0.8 |
–94.6 |
1,304.0 |
10,447.1 |
46.3 |
10,493.4 | ||
|
Adjustment IAS 19 |
– |
– |
– |
–11.6 |
12.5 |
– |
– |
– |
0.9 |
– |
0.9 | ||
|
Balance as of January 1, 2012 adjusted |
397.2 |
168.0 |
3,813.7 |
5,237.1 |
–378.2 |
0.8 |
–94.6 |
1,304.0 |
10,448.0 |
46.3 |
10,494.3 | ||
|
Profit after tax |
– |
– |
– |
294.9 |
– |
– |
– |
– |
294.9 |
8.3 |
303.3 | ||
|
Gains/losses recognized immediately in equity |
– |
– |
– |
– |
–92.1 |
1.2 |
20.2 |
33.7 |
–37.0 |
–0.4 |
–37.4 | ||
|
Comprehensive income |
– |
– |
– |
294.9 |
–92.1 |
1.2 |
20.2 |
33.7 |
258.0 |
7.9 |
265.9 | ||
|
Dividend payments |
– |
– |
– |
–96.9 |
– |
– |
– |
– |
–96.9 |
–5.3 |
–102.2 | ||
|
Profit transfers to/from E. Merck KG including transfers to reserves |
– |
– |
– |
–92.1 |
– |
– |
– |
– |
–92.1 |
– |
–92.1 | ||
|
Changes in scope of consolidation/ |
– |
– |
– |
–3.3 |
– |
– |
– |
– |
–3.3 |
3.6 |
0.2 | ||
|
Balance as of September 30, 2012 |
397.2 |
168.0 |
3,813.7 |
5,339.7 |
–470.3 |
2.0 |
–74.4 |
1,337.7 |
10,513.7 |
52.5 |
10,566.1 | ||
